Filing Details
- Accession Number:
- 0001415889-24-014673
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-28 16:30:07
- Reporting Period:
- 2024-05-23
- Accepted Time:
- 2024-05-28 16:30:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-23 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-23 | 645 | $274.50 | 3,085 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-23 | 1,347 | $275.54 | 1,738 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-23 | 1,247 | $276.36 | 491 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-23 | 361 | $277.03 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-05-24 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-24 | 234 | $270.92 | 3,496 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-24 | 1,959 | $272.01 | 1,537 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-24 | 1,014 | $272.85 | 523 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-24 | 146 | $273.94 | 377 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-24 | 125 | $275.28 | 252 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-24 | 88 | $276.63 | 164 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-24 | 34 | $277.27 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-05-23 | 3,600 | $0.00 | 3,600 | $129.49 |
| Common Stock | Stock Options | Disposition | 2024-05-24 | 3,600 | $0.00 | 3,600 | $129.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 227,069 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
| 223,469 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 166 | Indirect | By Spouse |
| Common Stock | 245,909 | Indirect | By Trust |
| Common Stock | 2,706 | Indirect | By Trust |
| Common Stock | 28,170 | Indirect | By Trust |
| Common Stock | 324,518 | Indirect | By Trust |
| Common Stock | 45,596 | Indirect | By Trust |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $273.87 to $274.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $274.94 to $275.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $275.98 to $276.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $270.56 to $271.495. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $271.57 to $272.505. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $272.58 to $273.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $273.60 to $274.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $274.955 to $275.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $276.085 to $276.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person is sole trustee and members of the Reporting Person's immediate family are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
Billionaire Hedge Funds
